The Funding Channels of Geroscience
- PMID: 36041881
- PMCID: PMC9808549
- DOI: 10.1101/cshperspect.a041210
The Funding Channels of Geroscience
Abstract
This review examines the interconnected channels of government, individual, and corporate funding for geroscience. A sometimes-slow flow of federal and philanthropic funding over 50 years is now becoming sufficient to understand how the processes of aging drive disease. The amount has not yet been enough to push the benefits of geroscience into new therapeutics, but that is poised to change. Prominent billionaires, venture capitalists, and new foundations are investing billions in researching approaches for preventing, delaying, or curing the chronic diseases of older people; major pharmaceutical companies are poised to join them once the Food and Drug Administration qualifies aging as a treatable condition. The coming decade could see considerable progress, not only in the science but also in the creation of fresh nonprofit and for-profit funding streams.
Copyright © 2023 Cold Spring Harbor Laboratory Press; all rights reserved.
References
-
- Friend T. 2017. Silicon Valley's quest to live forever. The New Yorker (March 27, 2017). https://www.newyorker.com/magazine/2017/04/03/silicon-valleys-quest-to-l...
-
- Fry R. 2020. Millennials overtake baby boomers as America's largest generation. Pew Research Center. http://pewrsr.ch/2FgVPwv
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical